A Novel Drug-Eluting Stent Coated With an Integrin-Binding Cyclic Arg-Gly-Asp Peptide Inhibits Neointimal Hyperplasia by Recruiting Endothelial Progenitor Cells
- 1 May 2006
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 47 (9) , 1786-1795
- https://doi.org/10.1016/j.jacc.2005.11.081
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Integrin Profile and In Vivo Homing of Human Smooth Muscle Progenitor CellsCirculation, 2004
- Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stentEuropean Heart Journal, 2004
- Downregulation of N-cadherin in the neointima stimulates migration of smooth muscle cells by RhoA deactivationCardiovascular Research, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Drug eluting stents: are human and animal studies comparable?Heart, 2003
- Expression Patterns of Integrins on Quiescent and Invasive Smooth Muscle Cells and Impact on Cell LocomotionJournal of Molecular and Cellular Cardiology, 2002
- Angiographic Findings of the Multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL)Circulation, 2002
- Cross-talk between α4β1/α5β1 and c-Kit results in opposing effect on growth and survival of hematopoietic cells via the activation of focal adhesion kinase, mitogen-activated protein kinase, and Akt signaling pathwaysBlood, 2001
- Abciximab Inhibits the Migration and Invasion Potential of Human Coronary Artery Smooth Muscle CellsJournal of Molecular and Cellular Cardiology, 2000
- Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis.The Journal of cell biology, 1996